Muscarinic vs. Nicotinic receptors - USMLE Forums
USMLE Forums Logo
USMLE Forums         Your Reliable USMLE Online Community     Members     Posts
USMLE Articles
Go Back   USMLE Forums > USMLE Step 1 Forum

USMLE Step 1 Forum USMLE Step 1 Discussion Forum: Let's talk about anything related to USMLE Step 1 exam

Thread Tools Search this Thread Display Modes
Old 05-23-2013
USMLE Forums Scout
Steps History: ---
Posts: 75
Threads: 12
Thanked 60 Times in 31 Posts
Reputation: 70
Default Muscarinic vs. Nicotinic receptors

I come across lots of these questions on muscarinic vs. nicotinic receptors on NBME questions.

Can anyone please confirm if my understanding is correct and also add on to the list of which diseases act on either the muscarinic or nicotinic receptors?



Muscarinic receptors:

Muscarinic receptors, or mAChRs, are acetylcholine receptors that form G protein-receptor complexes in the cell membranes of certain neurons and other cells. They play several roles, including acting as the main end-receptor stimulated by acetylcholine released from postganglionic fibers in the parasympathetic nervous system.

- tx Parkinson's disease
- prevent motion sickness
- treatment of COPD

Ligands targeting the mAChR that are currently approved for clinical use include non-selective antagonists for the treatment of Parkinson's disease, atropine (to dilate the pupil), Scopolamine (used to prevent motion sickness), and ipratropium (used in the treatment of COPD.


Nicotinic receptors:

Nicotinic acetylcholine receptors, or nAChRs, are cholinergic receptors that form ligand-gated ion channels in the plasma membranes of certain neurons and on the postsynaptic side of the neuromuscular junction. As ionotropic receptors, nAChRs are directly linked to ion channels and do not use second messengers (as metabotropic receptors do).

- tx Myasthenia gravis

Prolonged or repeat exposure to a stimulus often results in decreased responsiveness of that receptor toward a stimulus, termed desensitisation (for example: myasthenia gravis). nAChR function can be modulated by phosphorylation[16] by the activation of second messenger-dependent protein kinases


Please add on to the list.
Reply With Quote Quick reply to this message


Quick Reply

Register Now

In order to be able to post messages on the USMLE Forums forums, you must first register.
Please enter your desired user name, your email address and other required details in the form below.
User Name:
Please enter a password for your user account. Note that passwords are case-sensitive.
Confirm Password:
Email Address
Please enter a valid email address for yourself.
Email Address:
Medical School
Choose "---" if you don't want to tell. AMG for US & Canadian medical schools. IMG for all other medical schools.
USMLE Steps History
What steps finished! Example: 1+CK+CS+3 = Passed Step 1, Step 2 CK, Step 2 CS, and Step 3.

Choose "---" if you don't want to tell.

Favorite USMLE Books
What USMLE books you really think are useful. Leave blank if you don't want to tell.
Where you live. Leave blank if you don't want to tell.


Human Verification

In order to verify that you are a human and not a spam bot, please enter the answer into the following box below based on the instructions contained in the graphic.

Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Similar Threads
Thread Thread Starter Forum Replies Last Post
effect of Nicotinic stimulator drug on all ganglia tarsuc USMLE Step 1 Forum 0 12-18-2012 02:53 AM
NMDA receptors DrSeddik USMLE Step 1 Forum 9 12-06-2012 09:31 PM
Hormone Receptors lee-usmle USMLE Step 1 Bits & Pieces 1 08-05-2011 07:28 PM
JC Receptors doctorsmonsters USMLE Step 1 Forum 5 02-19-2011 10:32 PM
muscarinic and nicotinic receptors Seetal USMLE Step 1 Forum 2 04-08-2010 10:54 AM

RSS Feed
Find Us on Facebook
vBulletin Security provided by vBSecurity v2.2.2 (Pro) - vBulletin Mods & Addons Copyright © 2016 DragonByte Technologies Ltd.

USMLE® & other trade marks belong to their respective owners, read full disclaimer
USMLE Forums created under Creative Commons 3.0 License. (2009-2014)